P D Griffiths

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Antivirals in the transplant setting
    Paul D Griffiths
    Centre for Virology, Department of Infection, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom
    Antiviral Res 71:192-200. 2006
  2. ncbi Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
    Paul D Griffiths
    Centre for Virology, UCL Medical School, London, UK
    Lancet 377:1256-63. 2011
  3. ncbi CMV vaccine trial endpoints
    P D Griffiths
    Centre for Virology, University College London Medical School, United Kingdom
    J Clin Virol 46:S64-7. 2009
  4. ncbi Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007
    Paul Griffiths
    Royal Free and University College Medical School, London, UK
    Herpes 15:4-12. 2008
  5. ncbi Cytomegalovirus
    Paul D Griffiths
    Centre for Virology, Royal Free and University College Medical School, London, UK
    Curr Opin Infect Dis 18:241-5. 2005
  6. ncbi CMV as a cofactor enhancing progression of AIDS
    Paul D Griffiths
    Centre for Virology, The Royal Free and University College Medical School, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK
    J Clin Virol 35:489-92. 2006
  7. ncbi A perspective on antiviral resistance
    Paul D Griffiths
    Centre for Virology, UCL Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom
    J Clin Virol 46:3-8. 2009
  8. ncbi Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation
    G Nebbia
    Department of Infection, Royal Free and University College Medical School, London, UK
    Am J Transplant 8:2590-9. 2008
  9. ncbi Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts
    A F Hassan-Walker
    Department of Virology, Royal Free and University College Medical School, University College London, Royal Free Campus, Hampstead, London, United Kingdom
    J Med Virol 64:283-9. 2001
  10. ncbi Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
    V C Emery
    Department of Virology, Royal Free and University College Medical School, London, UK
    Lancet 355:2032-6. 2000

Research Grants

Collaborators

Detail Information

Publications59

  1. ncbi Antivirals in the transplant setting
    Paul D Griffiths
    Centre for Virology, Department of Infection, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom
    Antiviral Res 71:192-200. 2006
    ..This article will briefly summaries which viruses are important following transplantation and outline the evidence-base from randomized controlled clinical trails for the deployment of antiviral drugs to prevent viral diseases...
  2. ncbi Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
    Paul D Griffiths
    Centre for Virology, UCL Medical School, London, UK
    Lancet 377:1256-63. 2011
    ..Values of viral load correlate with development of end-organ disease and are moderated by pre-existing natural immunity. Our aim was to determine whether vaccine-induced immunity could do likewise...
  3. ncbi CMV vaccine trial endpoints
    P D Griffiths
    Centre for Virology, University College London Medical School, United Kingdom
    J Clin Virol 46:S64-7. 2009
    ..We should also ensure that the primary endpoint of a study immunising seronegative women is congenital CMV infection in babies born to those women, not to women in general, because of the large number of babies born to seropositives...
  4. ncbi Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007
    Paul Griffiths
    Royal Free and University College Medical School, London, UK
    Herpes 15:4-12. 2008
    ..For debate, we suggest that baseline pre-emptive therapy with oral valganciclovir should be the comparator for new drug evaluation because it is widely used in clinical practice in many groups of transplant patients...
  5. ncbi Cytomegalovirus
    Paul D Griffiths
    Centre for Virology, Royal Free and University College Medical School, London, UK
    Curr Opin Infect Dis 18:241-5. 2005
    ..To identify recent developments in the management of congenital cytomegalovirus infection which continues to exact a heavy toll on the developing central nervous system...
  6. ncbi CMV as a cofactor enhancing progression of AIDS
    Paul D Griffiths
    Centre for Virology, The Royal Free and University College Medical School, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK
    J Clin Virol 35:489-92. 2006
    ..Potential mechanisms which CMV could use as a cofactor have been described in vitro and potential criteria for assessing cofactor activity in vivo have been proposed...
  7. ncbi A perspective on antiviral resistance
    Paul D Griffiths
    Centre for Virology, UCL Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom
    J Clin Virol 46:3-8. 2009
    ....
  8. ncbi Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation
    G Nebbia
    Department of Infection, Royal Free and University College Medical School, London, UK
    Am J Transplant 8:2590-9. 2008
    ..Measuring polyfunctional CD4+ T cells against HCMV early posttransplant may allow targeted intervention to minimize the occurrence and acute and long-term consequences of HCMV replication...
  9. ncbi Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts
    A F Hassan-Walker
    Department of Virology, Royal Free and University College Medical School, University College London, Royal Free Campus, Hampstead, London, United Kingdom
    J Med Virol 64:283-9. 2001
    ..The transient nature of UL18 gene expression, and the low abundance of the transcript relative to gB were confirmed...
  10. ncbi Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
    V C Emery
    Department of Virology, Royal Free and University College Medical School, London, UK
    Lancet 355:2032-6. 2000
    ..Peak CMV load in the blood correlates with CMV disease but frequently occurs too late to provide prognostic information...
  11. ncbi Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation
    F M Mattes
    Department of Infection, Royal Free and University College Medical School Hampstead campus and Royal Free Hampstead NHS Trust, London, UK
    Am J Transplant 8:990-9. 2008
    ....
  12. ncbi CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus
    A F Hassan-Walker
    Department of Virology, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 183:835-43. 2001
    ..31; P=.005), which is consistent with the presence of a large proportion (70%) of activated (CD38(+)) ppUL83 CD8(+) CTL within the population of HLA class I tetramer-positive cells...
  13. ncbi The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophy
    P D Griffiths
    Virology Department, Royal Free Hospital School of Medicine, London, United Kingdom
    J Infect Dis 177:57-64. 1998
    ..02). Thus, PCR viremia provides prognostic information about CMV disease in AIDS patients, and valaciclovir showed activity as both a preemptive and prophylactic agent...
  14. ncbi Betaherpesviruses in transplant recipients
    P D Griffiths
    Department of Virology, Royal Free and University College Medical School, UK
    J Antimicrob Chemother 45:29-34. 2000
    ..The full clinicopathological significance of the betaherpesviruses may, thus, be greater than is currently appreciated...
  15. ncbi Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation
    P D Griffiths
    Department of Virology, Royal Free and University College Medical School, Royal Free Campus, London, UK
    Transpl Infect Dis 1:179-86. 1999
    ..Note..
  16. ncbi Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia
    C A Sabin
    Dept of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom NW3 2PF
    J Infect Dis 181:1800-3. 2000
    ..Thus, the effect of CMV seropositivity on clinical progression remains significant in this cohort but does not appear to be mediated through an increase in HIV RNA levels...
  17. ncbi Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7
    F M Mattes
    Department of Virology, Royal Free and University College Medical School, London, UK
    J Clin Pathol 53:612-4. 2000
    ..Human herpesvirus 6 (HHV-6) and HHV-7 are newer members of the beta-herpesvirinae that can cause febrile illness in young children and are also possible pathogens in the immunocompromised patient...
  18. ncbi Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy
    Jane R Deayton
    Department of Virology, Royal Free Hampstead NHS Trust and Royal Free and University College School of Medicine, London, UK
    AIDS 16:2129-35. 2002
    ..CONCLUSIONS: In patients with HCMV DNAaemia, reconstitution of humoral immunity to HCMV gB occurs rapidly following the initiation of HAART. These changes contrast with the patterns observed for anti-HIV humoral immune responses...
  19. ncbi Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
    J R Deayton
    Department of Virology, Royal Free Hampstead National Health Service Trust and Royal Free and University College School of Medicine, London, UK
    AIDS 14:1163-70. 2000
    ..To determine the effect of highly active antiretroviral therapy (HAART) on the natural history of cytomegalovirus (CMV) retinitis...
  20. ncbi Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
    Jane R Deayton
    Department of Virology, Royal Free and University College Medical School of University College London, Royal Free Campus, London, UK
    Lancet 363:2116-21. 2004
    ..Randomised controlled clinical trials of drugs active against cytomegalovirus are needed to investigate whether this virus is a marker or a determinant of HIV disease progression...
  21. ncbi Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation
    Paul Fiddian
    Royal Free and University College Medical School Royal Free Campus, London NW3 2PF, United Kingdom
    J Infect Dis 186:S110-5. 2002
    ..Increasing acyclovir exposure to that achieved with valacyclovir extends benefits of prophylaxis to include impact on graft rejection and opportunistic infections...
  22. ncbi Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy
    V C Emery
    Department of Virology, Royal Free and University College Medical School of University College, Rowland Hill Street, Hampstead, London, NW3 2QG, United Kingdom
    Proc Natl Acad Sci U S A 97:8039-44. 2000
    ..The modeled and experimental data showed excellent agreement over extended time periods (up to 270 days of therapy) and provide a framework to predict the virologic course of patients at therapeutic initiation...
  23. ncbi Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract
    C A Sabin
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, England
    J Med Virol 58:280-5. 1999
    ..Gastrointestinal adenovirus excretion occurs at an advanced stage of HIV disease, and is associated with a poor prognosis. We suggest that adenoviruses may contribute to mortality in this population...
  24. ncbi A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients
    Frank M Mattes
    Department of Virology, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 189:1355-61. 2004
    ..This study did not support a synergistic effect of ganciclovir plus foscarnet in vivo...
  25. ncbi Quantitation of porcine cytomegalovirus in pig tissues by PCR
    J F Fryer
    Department of Virology, Royal Free and University College Medical School of UCL, Rowland Hill Street, London NW3 2PF, United Kingdom
    J Clin Microbiol 39:1155-6. 2001
    ..This assay will have significant utility for studying the activation and replication of PCMV and in swine models for allo- and xenotransplantation...
  26. ncbi The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
    H C Buyck
    Department of Infection, Centre for Virology, UCL, London, UK
    Bone Marrow Transplant 45:1212-9. 2010
    ..Multivariable analysis of risk factors for HCMV DNAemia occurring beyond 100 days after transplant were older age, acute GVHD>grade II and a lower CD34 stem cell dose, whereas Campath-1H use was not associated with late HCMV DNAemia...
  27. ncbi Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy
    Hubertus C E Buyck
    Centre for Virology, Department of Infection, UCL London, United Kingdom
    J Clin Virol 49:32-6. 2010
    ..In some patients HCMV loads continue to increase after therapy and they experience multiple episodes of replication...
  28. ncbi Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir
    F M Mattes
    Centre for Virology, Division of Infection and Immunity, Royal Free and University College Medical School, London NW32QG, UK
    J Infect Dis 191:89-92. 2005
    ..73 days; P=.63). Preemptive therapy with VGCV provides control of HCMV replication that is comparable to that achieved with preemptive intravenous therapy with GCV...
  29. ncbi Susceptibility of porcine cytomegalovirus to antiviral drugs
    Jacqueline F L Fryer
    Centre for Virology, Department of Infection, Royal Free and University College Medical School of UCL, Hampstead Site, Rowland Hill Street, London NW3 2PF, UK
    J Antimicrob Chemother 53:975-80. 2004
    ..CONCLUSIONS: These results show that, if it proves necessary, ganciclovir and cidofovir should be considered as first-line drugs to treat PCMV infections in xenograft recipients...
  30. ncbi The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors
    Hoe Nam Leong
    Division of Infection and Immunity, Centre for Virology, Hampstead Campus, Royal Free and University College Medical School, London, UK
    J Med Virol 79:45-51. 2007
    ..8% of UK blood donors. The presence of high HHV-6 viral loads in healthy normal individuals reiterates the need to consider the confounding effect of HHV-6 viral integration in any laboratory diagnosis of HHV-6 infection...
  31. ncbi Evidence based management guidelines for the detection and treatment of congenital CMV
    S Kadambari
    Paediatric Infectious Diseases Unit, St George s University of London, Cranmer Terrace, London, United Kingdom
    Early Hum Dev 87:723-8. 2011
    ..In the last three years there have been significant advances in the diagnosis and treatment of congenital CMV. We have developed practical evidence based guidelines for the management of congenital CMV...
  32. ncbi Viral complications after transplantation
    P D Griffiths
    Division of Communicable Diseases, Royal Free Hospital School of Medicine, London, UK
    J Antimicrob Chemother 36:91-106. 1995
    ..After transplantation, patients have impaired immune responses, thereby rendering serology unreliable for diagnostic purposes. Instead, methods which detect the virus directly in clinical material should be used...
  33. ncbi Encouraging prospects for immunisation against primary cytomegalovirus infection
    P D Griffiths
    Department of Virology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, NW32PF, London
    Vaccine 19:1356-62. 2001
    ..In conclusion, CMV is a prime candidate for eradication from the human population through vaccination...
  34. ncbi Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus
    Aycan F Hassan-Walker
    Department of Virology, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom
    J Med Virol 74:573-9. 2004
    ..Mixed populations of HCMV strains occur in vivo so cloning of these strains is essential if an authentic genotype is to be defined...
  35. ncbi Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles
    Katherine N Ward
    Centre for Virology, Division of Infection and Immunity, Royal Free and University College Medical School UCL Campus, Windeyer Institute of Medical Sciences, 46 Cleveland St, London W1T 4JF, United Kingdom
    J Clin Microbiol 44:1571-4. 2006
    ..The characteristically high HHV-6 DNA levels in chromosomal integration may confound laboratory diagnosis of HHV-6 infection and should be given due consideration...
  36. ncbi Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir
    Paul D Griffiths
    Department of Virology, Royal Free and University College Medical School, Royal Free Campus, London NW3 2PF, United Kingdom
    J Infect Dis 186:S131-7. 2002
    ..In the future, clinicians should be alert to novel findings of randomized trials that may provide insight into the pathogenesis of these diseases and the contributions made by clinically silent herpesvirus infections...
  37. ncbi Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control
    Duncan A Clark
    Department of Virology, Royal Free and University College Medical School of UCL, Royal Free Campus, London, UK
    Xenotransplantation 10:142-8. 2003
    ..Our findings demonstrate that PCMV could be eradicated from pig herds being bred for xenotransplantation and argue that the spleen from donor animals should be examined as part of quality control procedures if clinical trials proceed...
  38. ncbi Human herpesvirus 6: relevance of infection in the immunocompromised host
    Duncan A Clark
    Department of Virology, Royal Free and University College Medical School of UCL, Royal Free Campus, London, UK
    Br J Haematol 120:384-95. 2003
  39. ncbi Strategies to prevent CMV infection in the neonate
    Paul D Griffiths
    Department of Virology, Royal Free Campus, Royal Free and University College Medical School, London, UK
    Semin Neonatol 7:293-9. 2002
    ....
  40. ncbi Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts
    Vincent C Emery
    Royal Free and University College Medical School, Dept of Virology, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK
    J Infect Dis 185:1723-8. 2002
    ....
  41. ncbi Resistance in viruses other than HIV
    Paul D Griffiths
    Royal Free and University College Medical School of UCL, London, UK
    Int J Infect Dis 6:S32-7. 2002
    ..Specific examples will be chosen to emphasize basic principles of the development of resistance and readers are referred elsewhere to a summary of resistance in HIV that follows the same principles...
  42. ncbi The 2001 Garrod lecture. The treatment of cytomegalovirus infection
    Paul D Griffiths
    Department of Virology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK
    J Antimicrob Chemother 49:243-53. 2002
    ..The controlled clinical trials performed to date will be summarized, together with suggestions about pharmacodynamic evaluations in the future...
  43. ncbi Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis
    Duncan A Clark
    Centre for Virology, Division of Infection and Immunity, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 193:912-6. 2006
    ..We suggest that the confounding influence of integration be considered in laboratory investigations associating HHV-6 with disease...
  44. ncbi Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report
    P J Bavin
    Division of Communicable Diseases, Royal Free Hospital School of Medicine, London, UK
    Br J Cancer 67:602-5. 1993
    ..The possibility of using such an approach for selecting women for more rapid or for routine colposcopy appointments in the two groups respectively is discussed...
  45. ncbi Cytomegalovirus therapy: current constraints and future opportunities
    P D Griffiths
    Department of Virology, Royal Free and University College Medical School, London, UK
    Curr Opin Infect Dis 14:765-8. 2001
    ..New treatments which are safe and potent are urgently needed and should be highly cost-effective when the full clinical impact of this virus is assessed...
  46. ncbi Primary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation
    G Nebbia
    Department of Virology, Royal Free and University College Hospital, London, UK
    Transpl Infect Dis 8:229-32. 2006
    ..In this setting, real-time polymerase chain reaction applied to blood samples provides a sensitive, rapid, and quantitative diagnostic tool...
  47. ncbi Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients
    Duncan A Clark
    Department of Virology, Royal Free and University College Medical School of UCL, London, UK
    Semin Hematol 40:154-62. 2003
    ..Both of these newer herpesviruses are potentially susceptible to existing and licensed antiherpesvirus drugs...
  48. ncbi Infrequency of pulmonary microbial colonisation prior to respiratory disease in HIV-infected individuals
    M C Lipman
    Division of Communicable Disease, Royal Free Hospital and School of Medicine, London, UK
    Eur J Clin Microbiol Infect Dis 19:699-703. 2000
    ..This has implications for the understanding of the pathogenesis of HIV-related pulmonary disease...
  49. ncbi Microarray-based determination of the lytic cascade of human herpesvirus 6B
    Edward H Tsao
    Department of Infection, Division of Infection and Immunity, Royal Free and University College Medical School of UCL, London, UK
    J Gen Virol 90:2581-91. 2009
    ..Clustering of genes with similar expression profiles implied a shared function, thus revealing possible roles of previously uncharacterized HHV-6B genes...
  50. ncbi Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function
    Ying Ting Li
    Department of Infection, University College Medical School Campus, Rowland Hill Street, Hampstead, London, UK
    J Med Virol 82:85-93. 2010
    ..HCMV DNA is frequently detected in renal tubular epithelial cells early after renal transplantation, precedes DNAemia and is associated with poor long-term graft function...
  51. ncbi Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains
    P W Tuke
    Centre for Virology, Department of Infection, Royal Free and University College Medical School of UCL, Hampstead Site, Rowland Hill Street, London NW3 2PF, UK
    Mult Scler 10:355-9. 2004
    ..These studies confirm the neurotropism of HHV-6 but do not demonstrate differences in the distribution, variant type or quantity of HHV-6 in brains from patients with MS versus controls...
  52. ncbi Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides
    Nigel J Temperton
    Department of Virology, Royal Free and University College Medical School, London, United Kingdom
    J Med Virol 70:86-90. 2003
    ..The results provide a rationale for evaluating combinations of other HCMV proteins for incorporation into a multi-target DNA vaccine, and for the optimization of adjuvant usage, to elicit enhanced levels of neutralizing antibodies. 2003...
  53. ncbi Genetic content of wild-type human cytomegalovirus
    Aidan Dolan
    MRC Virology Unit, Institute of Virology, Church Street, Glasgow G11 5JR, UK
    J Gen Virol 85:1301-12. 2004
    ..The case in support of a lack of protein-coding potential in the region between UL105 and UL111A was also strengthened...
  54. ncbi Clinical xenotransplantation
    Duncan A Clark
    Lancet 362:1421. 2003
  55. ncbi Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis
    Roland R Regoes
    Ecology and Evolution, Swiss Federal Institute of Technology Zurich, ETH Zentrum NW, Zurich, Switzerland
    Proc Biol Sci 273:1961-7. 2006
    ..The model accurately predicted the time of disease onset for fever, gastrointestinal disease and pneumonitis but not for hepatitis and retinitis, implying that other factors may be involved in the pathology of these diseases...
  56. ncbi Opportunities and challenges
    Paul D Griffiths
    Herpes 10:31. 2003
  57. ncbi Two novel spliced genes in human cytomegalovirus
    Parvis Akter
    MRC Virology Unit, Institute of Virology, Church Street, Glasgow G11 5JR, UK
    J Gen Virol 84:1117-22. 2003
    ..Although the functions of these genes are unknown, sequence comparisons suggest that UL128 encodes a beta-chemokine...
  58. ncbi Fomivirsen for the treatment of cytomegalovirus retinitis
    Douglas A Jabs
    Am J Ophthalmol 133:552-6. 2002
  59. ncbi Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes
    Andrew J Davison
    MRC Virology Unit, Institute of Virology, Church Street, Glasgow G11 5JR, Scotland, UK
    J Gen Virol 84:657-63. 2003
    ..These features prompt speculation about the roles of these genes in the two virus families...

Research Grants5

  1. PHASE IB TRIAL OF CYTOMEGALOVIRUS GLYCOPROTEIN B VACCINE
    Paul Griffiths; Fiscal Year: 2006
    ..If a vaccine schedule can be identified which controls viral load, this will be recommended for a phase II placebo-controlled trial of clinical efficacy. ..